Regulatory Approval Success Rate is a critical KPI that reflects an organization's ability to navigate complex regulatory landscapes efficiently.
High success rates lead to faster product launches and reduced costs associated with delays, ultimately enhancing operational efficiency.
This metric directly influences financial health by minimizing the risk of non-compliance penalties and fostering strategic alignment with market demands.
Companies that excel in this area can better allocate resources, improve forecasting accuracy, and achieve superior ROI metrics.
Monitoring this KPI enables data-driven decision-making, ensuring that organizations remain agile and competitive in their sectors.
A high Regulatory Approval Success Rate indicates effective compliance strategies and streamlined processes, while a low rate suggests potential inefficiencies or regulatory misalignment. Ideal targets typically exceed 85%, signaling robust management reporting and proactive risk management.
We have 4 relevant benchmarks in our benchmarks database.
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | FY 2002–2004 | NME NDAs and BLAs reaching first action | human drugs and biologics | United States | 77 submissions |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | 2014–2016 | 107 new drug applications with a regulatory outcome at both | pharmaceuticals | United States and Europe | 107 |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | FY 2022 | NDA and BLA applications filed in FY 2022 and approved durin | human drugs and biologics | United States |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | 2011–2020 | NDA/BLA submissions | United States | 1,453 |
Many organizations overlook the importance of continuous regulatory training, which can lead to outdated knowledge and compliance failures.
Enhancing the Regulatory Approval Success Rate requires a proactive approach to compliance and collaboration across departments.
A leading pharmaceutical company faced challenges with its Regulatory Approval Success Rate, which hovered around 65%. This low rate delayed product launches and increased costs associated with compliance. To address this, the company initiated a comprehensive review of its submission processes and established a dedicated regulatory affairs team. They implemented a new digital platform that centralized documentation and improved collaboration among departments.
Within a year, the company saw its success rate rise to 90%. This improvement significantly reduced time-to-market for new drugs, allowing the firm to capture market share more effectively. The enhanced process also led to a decrease in compliance-related penalties, contributing positively to the company's financial health.
The initiative not only streamlined operations but also fostered a culture of accountability and continuous learning. Employees were encouraged to share insights and best practices, which further enhanced the company's ability to adapt to regulatory changes.
As a result, the company positioned itself as a leader in regulatory compliance, gaining recognition in the industry for its efficient processes and commitment to quality. This transformation not only improved the bottom line but also strengthened relationships with regulatory agencies, paving the way for future innovations.
This KPI is associated with the following categories and industries in our KPI database:
KPI Depot takes you from KPI intelligence to finished deliverable. Consultants, strategy teams, FP&A leaders, and analytics teams use it to answer the two hardest questions in performance management, what to measure and what the target should be, and then to produce the scorecard itself.
The difference is intelligence, not just data. Anyone can list metrics. Every KPI in KPI Depot carries 13 practical attributes, from formula and measurement approach to diagnostic questions, risk warnings, and Balanced Scorecard perspective, across 15 corporate functions and 153 industries. And every target you set is grounded in our database of 34,304 source-attributed benchmarks, each detailing metric value, company size, time period, industry, geography, sample size, and source. Benchmark data at this scale is otherwise the domain of research services costing thousands to hundreds of thousands of dollars per year.
When your metrics are selected, KPI Depot finishes the job: export an interactive Strategy Map, a Balanced Scorecard with formulas and tracking columns, or a CSV KPI pack, and go from research to working deliverable in hours instead of weeks.
Formerly the Flevy KPI Library, KPI Depot is trusted by teams at organizations including Accenture, EY, IBM, PepsiCo, Samsung, and Vodafone.
Got a question? Email us at [email protected].
Several factors can impact this KPI, including the complexity of regulations, the quality of submissions, and the level of stakeholder engagement. Organizations that prioritize compliance and streamline processes tend to achieve higher success rates.
Technology can enhance efficiency by automating documentation and tracking changes in regulations. Digital platforms also facilitate collaboration among teams, reducing the likelihood of errors and improving submission quality.
Regular training ensures that employees are up-to-date on regulatory requirements and best practices. This knowledge is crucial for minimizing compliance risks and improving the likelihood of successful approvals.
Organizations should conduct regular reviews, ideally quarterly, to ensure that their processes remain aligned with current regulations. Frequent assessments help identify areas for improvement and foster a culture of continuous compliance.
Yes, external consultants can provide valuable insights and expertise in navigating complex regulatory environments. Their experience can help organizations identify gaps and implement best practices for successful submissions.
A low success rate can lead to increased costs, delayed product launches, and potential legal penalties. It can also damage an organization's reputation and hinder its ability to compete effectively in the market.
Each KPI in our knowledge base includes 13 attributes.
A clear explanation of what the KPI measures
The typical business insights we expect to gain through the tracking of this KPI
An outline of the approach or process followed to measure this KPI
The standard formula organizations use to calculate this KPI
Insights into how the KPI tends to evolve over time and what trends could indicate positive or negative performance shifts
Questions to ask to better understand your current position is for the KPI and how it can improve
Practical, actionable tips for improving the KPI, which might involve operational changes, strategic shifts, or tactical actions
Recommended charts or graphs that best represent the trends and patterns around the KPI for more effective reporting and decision-making
Potential risks or warnings signs that could indicate underlying issues that require immediate attention
Suggested tools, technologies, and software that can help in tracking and analyzing the KPI more effectively
How the KPI can be integrated with other business systems and processes for holistic strategic performance management
Explanation of how changes in the KPI can impact other KPIs and what kind of changes can be expected
NEW Mapping to a Balanced Scorecard perspective (financial, customer, internal process, learning & growth)